Gizem Rizki
Senior Principal Scientist Novartis AG
Seminars
Wednesday 29th April 2026
Panel Discussion: Planning Ahead for CIVM Development to Ensure Models Are Ready for Critical Research Questions
3:45 pm
- Anticipating future research needs early to reduce delays and accelerate model implementation when questions arise
- Evaluating existing platforms versus new models to minimize cost and time while maintaining scientific rigor
- Engaging senior leadership in proactive planning to align resources and timelines for complex model development
Tuesday 28th April 2026
Advancing Cell Sourcing Strategies to Minimize Variability & Overcome Primary Cell Scarcity
1:00 pm
Even the most validated models fail without high-quality cells. Limited access to primary cells and batch-to-batch variability pose major challenges for reproducibility and scalability. This workshop examines sourcing strategies, IPSC applications, and centralized approaches to ensure sufficient, consistent cells for 3D tissue models. Learn how companies streamline cell acquisition and address patient heterogeneity for more predictive complex in vitro systems.
- Centralizing primary cell sourcing to reduce variability and achieve consistent readouts
- Evaluating iPSC benefits and limitations to expand cell availability and accelerate iPSC development timelines
- Streamlining cell acquisition from clinics to minimize human error and variability in cell quality
- Addressing low primary cell availability to capture patient heterogeneity and improve model predictability
